Skip to content
Comparison

Ipamorelin + CJC-1295 vs Tesamorelin

Ipamorelin + CJC-1295 and Tesamorelin are commonly compared for best GH peptide strategies by evidence and goal fit. Ipamorelin + CJC-1295 is usually favored for rank #1 for flexible GH pulse optimization, while Tesamorelin is often preferred for rank #2 for visceral-fat oriented clinically supervised use. This head-to-head analysis focuses on mechanism, trial outcomes, dosing context, evidence quality, regulatory status, and practical decision points for safer YMYL decision-making.

4.3(112 ratings)

Quick Answer

For best GH peptide strategies by evidence and goal fit, the better choice depends on your primary endpoint. Ipamorelin + CJC-1295 is stronger when the priority is custom GH optimization stack protocols. Tesamorelin is stronger when the priority is visceral-fat focused GH-axis treatment. Use evidence grade, dose intensity, access constraints, and tolerability profile to match therapy to the patient profile rather than choosing by hype alone.

Head-to-Head Comparison

CriteriaIpamorelin + CJC-1295Tesamorelin
Primary mechanismGHRP + GHRH synergy for amplified GH pulse generationFDA-approved GHRH analog for HIV lipodystrophy
Strongest clinical signalStronger GH pulse architecture than either agent aloneStrong visceral-fat reduction in indicated populations
Typical dosing contextOften 100-200 mcg of each peptide per dose, 1-3x daily2 mg daily in approved protocol
AdministrationSubcutaneous injectionSubcutaneous injection
Evidence quality gradeModerate mechanistic support and extensive protocol useStrong in HIV-lipodystrophy; moderate extrapolation outside indication
Regulatory statusNot FDA-approved combinationFDA-approved for HIV-associated lipodystrophy
Side-effect burdenDepends on dose and frequency; monitor IGF-1/metabolic markersMonitor glucose tolerance and IGF-1 trends
Cost/access contextHigher than single-agent protocolsHigh branded and clinic cost
Best candidate profileUsers aiming for pulse-amplified GH optimizationVisceral-adiposity endpoints with clinical supervision
Main limitationProtocol complexity and adherence burdenExpensive and indication-specific evidence concentration
Best use case in this comparisoncustom GH optimization stack protocolsvisceral-fat focused GH-axis treatment

When to Choose Each

Choose Ipamorelin + CJC-1295

Best for custom GH optimization stack protocols.

Choose Tesamorelin

Best for visceral-fat focused GH-axis treatment.

Verdict

If the main goal is custom GH optimization stack protocols, Ipamorelin + CJC-1295 is usually the better first-line choice. If the main goal is visceral-fat focused GH-axis treatment, Tesamorelin is typically the better fit. Reassess outcomes at 8-16 weeks with objective metrics, then adjust only when response, safety, or adherence data justify it. In high-risk populations, physician-guided personalization matters more than any generic ranking.

References

  1. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults (2006) — PubMed
  2. Ipamorelin, the first selective growth hormone secretagogue (1998) — PubMed
  3. Ghrelin is a growth-hormone-releasing acylated peptide from stomach (1999) — PubMed
  4. A synthetic GH secretagogue (MK-677) and a GHRH analog (CJC-1295) act synergistically to promote GH release in humans (2008) — PubMed

Compare Telehealth Providers

Find the right provider for your peptide therapy needs

Hims & Hers

Most Popular
4.3

Starting at $199/mo

Hims & Hers is a leading telehealth platform offering physician-supervised GLP-1 weight loss programs including compounded semaglutide and tirzepatide. Board-certified providers, async or video consults, and medication shipped to your door.

✓Large, established platform with strong physician network
✓Compounded semaglutide available where branded shortages exist
✓Easy async consult — no video call required
✗Does not offer a wide range of peptides beyond GLP-1s
✗Pricing is on the higher end for GLP-1 programs

Henry Meds

Most Peptides
4.2

Starting at $249/mo

Henry Meds is a telehealth provider specializing in hormone optimization and peptide therapy. Beyond GLP-1 weight loss, Henry Meds offers testosterone replacement therapy, growth hormone peptides, and other advanced hormonal protocols managed by licensed physicians.

✓Broadest peptide therapy menu of any major telehealth provider
✓Growth hormone peptides (sermorelin, ipamorelin, CJC-1295) available
✓Repair peptides including BPC-157 and TB-500
✗Higher starting price due to comprehensive programs
✗More complex onboarding including lab work requirements

Ro Body

Best Value
4.1

Starting at $149/mo

Ro Body is a telehealth weight management program powered by GLP-1 medications. Ro connects patients with licensed providers who prescribe compounded semaglutide or branded GLP-1 therapies depending on eligibility, paired with behavioral coaching.

✓Competitive pricing starting at $149/mo
✓Dedicated health coach included in program
✓Strong clinical protocols with lab-work integration
✗Narrower peptide offering — GLP-1s only
✗Video consult required for initial visit

Calibrate

4.0

Starting at $199/mo

Calibrate is a metabolic health company offering a one-year GLP-1 program built around four pillars: food, sleep, exercise, and emotional health. Calibrate works with insurance to cover medication costs and provides extensive behavioral coaching alongside prescriptions.

✓Insurance navigation support for medication coverage
✓Evidence-based one-year program with structured milestones
✓Four-pillar lifestyle coaching (food, sleep, exercise, emotional health)
✗Annual program commitment required
✗Primarily focused on GLP-1s — no broader peptide therapy

Found

3.9

Starting at $129/mo

Found is a weight management telehealth platform that combines GLP-1 medications with behavioral coaching and a supportive community. Found emphasizes a whole-person approach, pairing pharmacological treatment with lifestyle intervention for sustainable results.

✓One of the more affordable monthly program fees
✓Strong community and peer support features
✓Certified health coaches with regular check-ins
✗Medication billed separately from program fee — total cost can be higher
✗Limited peptide variety beyond standard GLP-1s

Sponsored · We may earn a commission. Learn more · Updated February 2026

Henry MedsMost Peptides

Henry Meds is a telehealth provider specializing in hormone optimization and peptide therapy. Beyond GLP-1 weight loss, Henry Meds offers testosterone replacement therapy, growth hormone peptides, and other advanced hormonal protocols managed by licensed physicians.

From $249/moLearn More →

Sponsored · Affiliate Disclosure

Frequently Asked Questions

Which has stronger evidence for best GH peptide strategies by evidence and goal fit — Ipamorelin + CJC-1295 or Tesamorelin?
Ipamorelin + CJC-1295 is graded as moderate mechanistic support and extensive protocol use evidence in this context, while Tesamorelin is graded as strong in hiv-lipodystrophy; moderate extrapolation outside indication. In practice, strength depends on whether you prioritize custom GH optimization stack protocols or visceral-fat focused GH-axis treatment. Favor the option with endpoint data closest to your primary goal, and avoid extrapolating beyond studied populations.
Can Ipamorelin + CJC-1295 and Tesamorelin be combined or sequenced?
Sometimes, but only with clinician oversight. A common framework is to start with one agent, track objective response for 8-16 weeks, then switch or sequence if outcomes plateau or tolerability is poor. Combination protocols may increase both cost and adverse-effect complexity, so they should be justified by clear endpoint-based rationale.
What should be monitored before and during treatment?
Baseline assessment should include diagnosis confirmation, comorbidity risk, and contraindications. During therapy, monitor target outcomes (symptoms, body composition, labs), adverse effects, and adherence burden. For endocrine/metabolic strategies, periodic glucose, lipids, organ function, and indication-specific labs help keep risk proportional to expected benefit.

Explore next